Scooping up the shares it doesn’t already own, Alkermes Inc. agreed to purchase the remaining 81 percent of Reliant Pharmaceuticals LLC in a stock deal worth about $934 million. (BioWorld Today)

Scooping up the shares it doesn’t already own, Alkermes Inc. agreed to purchase the remaining 81 percent of Reliant Pharmaceuticals LLC in a stock deal worth about $934 million. (BioWorld Today)